Diffuse parenchymal lung disease

Medicine (United Kingdom)

Volumn 40, Issue 6, 2012, Pages 314-321

  Maher, Toby M ^a,b  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

idiopathic pulmonary fibrosis; interstitial lung disease; Langerhans cell histiocytosis; organizing pneumonia; sarcoidosis

Indexed keywords

ACETYLCYSTEINE; ALLERGEN; AZATHIOPRINE; CLADRIBINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE; HERBACEOUS AGENT; ILLICIT DRUG; METHYLPREDNISOLONE; NEUTROPHIL CYTOPLASMIC ANTIBODY; NINTEDANIB; NON PRESCRIPTION DRUG; PIRFENIDONE; PREDNISOLONE; PRESCRIPTION DRUG; RAPAMYCIN;

ALLERGIC PNEUMONITIS; ARTICLE; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; BRONCHOSCOPY; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; CLUBBING FINGERS; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; CYANOSIS; DIFFUSE PARENCHYMA LUNG DISEASE; DISEASE COURSE; DRUG ERUPTION; DRUG MEGADOSE; FAMILY HISTORY; FIBROSING ALVEOLITIS; GASTROINTESTINAL SYMPTOM; HERBAL MEDICINE; HISTIOCYTOSIS X; HISTOLOGY; HUMAN; HYPOXIA; INTERSTITIAL PNEUMONIA; LIVER TOXICITY; LUNG BIOPSY; LUNG DISEASE; LUNG EXAMINATION; LUNG FUNCTION; LUNG LAVAGE; LUNG TRANSPLANTATION; LYMPHANGIOLEIOMYOMATOSIS; MEDICAL HISTORY; OCCUPATIONAL EXPOSURE; OXYGEN THERAPY; PATHOGENESIS; PHOTOSENSITIVITY; PRIORITY JOURNAL; PROGNOSIS; RETREATMENT; SEROLOGY; TACHYPNEA; THORAX RADIOGRAPHY;

EID: 84862100915     PISSN: 13573039     EISSN: 13654357     Source Type: Journal    
DOI: 10.1016/j.mpmed.2012.03.007     Document Type: Review

References (13)

1. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001 Am J Respir Crit Care Med 165 2002 277 304
2. V. Navaratnam, K.M. Fleming, and J. West The rising incidence of idiopathic pulmonary fibrosis in the UK Thorax 66 2011 462 467
3. T.M. Maher, A.U. Wells, and G.J. Laurent Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms? Eur Respir J 30 2007 835 839 (Pubitemid 351194784)
4. M. Selman, T.E. King, and A. Pardo Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy Ann Intern Med 134 2001 136 151 (Pubitemid 32096342)
5. P.W. Noble, C. Albera, and W.Z. Bradford Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials Lancet 377 2011 1760 1769
6. M. Demedts, J. Behr, and R. Buhl High-dose acetylcysteine in idiopathic pulmonary fibrosis N Engl J Med 353 2005 2229 2242 (Pubitemid 41697286)
7. L. Richeldi, U. Costabel, and M. Selman Efficacy of a tyrosine kinase inhibitor in idiopathic fibrosis N Engl J Med 365 2011 1079 1087
8. Idiopathic Pulmonary Fibrosis Clinical Research Network, D.A. Zisman, and M. Schwarz A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis N Engl J Med 363 2010 620 628
9. D.P. Tashkin, R. Elashoff, and P.J. Clements Cyclophosphamide versus placebo in scleroderma lung disease N Engl J Med 354 2006 2655 2666
10. R. Lazor, A. Vandevenne, A. Pelletier, P. Leclerc, Court-Fortune, and J.F. Cordier Cryptogenic organizing pneumonia. Characteristics of relapses in a series of 48 patients. The Groupe d'Etudes et de Recherche sur les Maladles "Orphelines" Pulmonaires (GERM"O"P) Am J Respir Crit Care Med 162 2000 571 577
11. B. Ng-Cheng-Hin, C. O'Hanlon-Brown, C. Alifrangis, and J. Waxman Langerhans cell histiocytosis: old disease new treatment QJM 104 2011 89 96
12. F.X. McCormack, Y. Inoue, and J. Moss Efficacy and safety of sirolimus in lymphangioleiomyomatosis N Engl J Med 364 2011 1595 1606
13. A.M. Taveira-DaSilva, O. Hathaway, M. Stylianou, and J. Moss Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus Ann Intern Med 154 2011 797 805